Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

Current methods for differentiating isolates of predominant lineages of pathogenic bacteria
often do not provide sufficient resolution to define precise relationships. Here, we describe a …

Staphylococcus aureus bacteraemia is one of the most common serious bacterial infections
worldwide. In the UK alone, around 12 500 cases each year are reported, with an …

Prognostic characteristics inform risk stratification in intensive care unit (ICU) patients with
coronavirus disease 2019 (COVID-19). We obtained blood samples (n = 474) from …

COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …

Objectives Staphylococcus aureus bacteraemia is a common, often fatal infection. Our aim
was to describe how its clinical presentation varies between populations and to identify …

Background Surface-active antiseptics, such as chlorhexidine, are increasingly being used
as part of intervention programs to prevent methicillin-resistant Staphylococcus aureus (…

Background Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone
of SARS-CoV-2 mass community testing, although their reduced sensitivity compared …

The 3.1-Mb genome of an outbreak methicillin-resistant Staphylococcus aureus (MRSA) strain
(TW20) contains evidence of recently acquired DNA, including two large regions (635 kb …

Introduction. During previous viral pandemics, reported co-infection rates and implicated
pathogens have varied. In the 1918 influenza pandemic, a large proportion of severe illness …